Human periosteum-derived cells from elderly patients as a source for cartilage tissue engineering?

Journal of Tissue Engineering and Regenerative Medicine

Volumn 2, Issue 6, 2008, Pages 331-339

  Jansen, Edwin J P ^a   Emans, Pieter J ^a   Guldemond, Nick A ^a   Van Rhijn, Lodewijk W ^a   Welting, Tim J M ^a   Bulstra, Sjoerd K ^b   Kuijer, Roel ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cell culture; Chondrogenic differentiation; FGF 2; IGF 1; Mesenchymal stem cells; Periosteum; TGF ; Tissue engineering

Indexed keywords

AMINO ACIDS; BODY FLUIDS; CARTILAGE; CELL ENGINEERING; ISOMERS; STEM CELLS; TISSUE ENGINEERING;

CARTILAGE TISSUE ENGINEERING; CHONDROGENIC DIFFERENTIATION; D-VALINE; FIBROBLAST GROWTH FACTOR-2; INSULIN-LIKE GROWTH FACTOR-1; MESENCHYMAL STEM CELL; PERIOSTEUM; TISSUES ENGINEERINGS; TRANSFORMING GROWTH FACTOR-Β; TRANSFORMING GROWTH FACTORS;

CELL CULTURE;

AMINO ACID; COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGEN TYPE 2; FIBROBLAST GROWTH FACTOR 2; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; VALINE; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; ARTICULAR CARTILAGE; BONE BIOPSY; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CHONDROGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; CULTURE OPTIMIZATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; ISOMER; NUCLEOTIDE SEQUENCE; PERIOSTEUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERUM; STEM CELL EXPANSION; TIBIA; TISSUE ENGINEERING; CARTILAGE; CELL CULTURE; CELL SEPARATION; CULTURE TECHNIQUE; CYTOLOGY; METABOLISM; METHODOLOGY; MIDDLE AGED;

ADULT; AGED; BIOLOGICAL MARKERS; CARTILAGE; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL SEPARATION; CELLS, CULTURED; CHONDROGENESIS; FEMALE; HUMANS; MIDDLE AGED; PERIOSTEUM; TISSUE ENGINEERING;

EID: 60749132867     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.100     Document Type: Article

References (65)

1. Andereya S, Maus U, Gavenis K, et al. 2006; First clinical experiences with a novel 3D-collagen gel (CaReS) for the treatment of focal cartilage defects in the knee. Z Orthop Ihre Grenzgeb 144: 272-280.
2. Armati PJ, Constable AL, Llewellyn F. 1990; A new medium for in vitro peripheral nervous tissue myelination without the use of antimitotics. J Neurosci Methods 33: 149-155.
3. Barry F, Boynton RE, Liu B, et al. 2001; Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiationdependent gene expression of matrix components. Exp Cell Res 268: 189-200.
4. Beresford JN. 1989; Osteogenic stem cells and the stromal system of bone and marrow. Clin Orthop Relat Res 240: 270-280.
5. Bouwmeester SJ, Beckers JM, Kuijer R, et al. 1997; Long-term results of rib perichondrial grafts for the repair of cartilage defects in the human knee. Int Orthopaed 21: 313-317.
6. Bouwmeester SJ, Kuijer R, Homminga GN, et al. 2002; A retrospective analysis of two independent prospective cartilage repair studies: autogenous perichondrial grafting versus subchondral drilling 10 years post-surgery. J Orthop Res 20: 267-273.
7. Brittberg M, Peterson L, Sjogren-Jansson E, et al. 2003; Articular cartilage engineering with autologous chondrocyte transplantation. A review of recent developments. J Bone Joint Surg (Am) 85A(suppl 3): 109-115.
8. Brownlow HC, Reed A, Joyner C, et al. 2000; Anatomical effects of periosteal elevation. J Orthop Res 18: 500-502.
9. Choi YS, LimSM, ShinHC, et al. 2007; Chondrogenesis of human periosteum-derived progenitor cells in atelocollagen. Biotechnol Lett 29: 323-329.
10. Choi YS, Noh SE, Lim SM, et al. 2008; Multipotency and growth characteristic of periosteum-derived progenitor cells for chondrogenic, osteogenic, and adipogenic differentiation. Biotechnol Lett 30: 593-601.
11. De Bari C, Dell'Accio F, Luyten FP. 2001; Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. Arthrit Rheum 44: 85-95.
12. De Bari C, Dell'Accio F, Vanlauwe J, et al. 2006; Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthrit Rheum 54: 1209-1221.
13. Dharmavaram RM, Baldwin CT, Reginato AM, et al. 1993; Amplification of cDNAs for human cartilage-specific types II, IX and XI collagens from chondrocytes and Epstein-Barr virustransformed lymphocytes. Matrix 13: 125-133.
14. Dorshkind K. 1990; Regulation of hemopoiesis by bone marrow stromal cells and their products. Annu Rev Immunol 8: 111-137.
15. Emans PJ, Surtel DAM, Frings EJJ, et al. 2005; In vivo generation of cartilage out of periosteum. Tissue Eng 11: 369-377.
16. Erggelet C, Sittinger M, Lahm A. 2003; The arthroscopic implantation of autologous chondrocytes for the treatment of full-thickness cartilage defects of the knee joint. Arthroscopy 19: 108-110.
17. Erickson GR, Gimble JM, Franklin DM, et al. 2002; Chondrogenic potential of adipose tissue-derived stromal cells in vitro and in vivo. Biochem Biophys Res Commun 290: 763-769.
18. Estes BT, Wu AW, Guilak F. 2006; Potent induction of chondrocytic differentiation of human adipose-derived adult stem cells by bone morphogenetic protein 6. Arthrit Rheum 54: 1222-1232.
19. Fitzsimmons JS, Sanyal A, Gonzalez C, et al. 2004; Serum-free media for periosteal chondrogenesis in vitro. J Orthop Res 22: 716-725.
20. Frauli M, Ludwig H. 1987; Inhibition of fibroblast proliferation in a culture of human endometrial stromal cells using a medium containing D-valine. Arch Gynecol Obstet 241: 87-96.
21. Fukumoto T, Sperling JW, Sanyal A, et al. 2003; Combined effects of insulin-like growth factor-1 and transforming growth factor-β1 on periosteal mesenchymal cells during chondrogenesis in vitro. Osteoarthrit Cartilage 11: 55-64.
22. Gelber AC, Hochberg MC, Mead LA, et al. 2000; Joint injury in young adults and risk for subsequent knee and hip osteoarthritis. Ann Intern Med 133: 321-328.
23. Gilbert SF,Migeon BR. 1975; D-Valine as a selective agent for normal human and rodent epithelial cells in culture. Cell 5: 11-17.
24. Hauselmann HJ, Aydelotte MB, Schumacher BL, et al. 1992; Synthesis and turnover of proteoglycans by human and bovine adult articular chondrocytes cultured in alginate beads. Matrix 12: 116-129.
25. Hennig T, Lorenz H, Thiel A, et al. 2007; Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFβ receptor and BMP profile and is overcome by BMP-6. J Cell Physiol 211: 682-691.
26. Huang CY, Reuben PM, D'Ippolito G, et al. 2004; Chondrogenesis of human bone marrow-derived mesenchymal stem cells in agarose culture. Anat Rec A Discov Mol Cell Evol Biol 278: 428-436.
27. Huang JI, Kazmi N, Durbhakula MM, et al. 2005; Chondrogenic potential of progenitor cells derived from human bone marrow and adipose tissue: a patient-matched comparison. J Orthop Res 23: 1383-1389.
28. Hunt N, Sanchez-Ballester J, Pandit R, et al. 2001; Chondral lesions of the knee: a new localization method and correlation with associated pathology. Arthroscopy 17: 481-490.
29. Indrawattana N, Chen G, Tadokoro M, et al. 2004; Growth factor combination for chondrogenic induction from human mesenchymal stem cell. Biochem Biophys Res Commun 320: 914-919.
30. Ito Y, Fitzsimmons JS, Sanyal A, et al. 2001; Localization of chondrocyte precursors in periosteum. Osteoarthrit Cartilage 9: 215-223.
31. Iwasaki M, Nakahara H, Nakata K, et al. 1995; Regulation of proliferation and osteochondrogenic differentiation of periosteumderived cells by transforming growth factor-β and basic fibroblast growth factor. J Bone Joint Surg (Am) 77: 543-554.
32. Iwasaki M, Nakata K, Nakahara H, et al. 1993; Transforming growth factor-β1 stimulates chondrogenesis and inhibits osteogenesis in high density culture of periosteum-derived cells. Endocrinology 132: 1603-1608.
33. Kafienah W, Mistry S, Perry MJ, et al. 2007; Pharmacological regulation of adult stem cells: chondrogenesis can be induced using a synthetic inhibitor of the retinoic acid receptor. Stem Cells 25: 2460-2468.
34. Kuijer R, Surtel DAM, Passier RCJJ, et al. 1998; A novel method to examine the phenotype of chondrocytes. J Mater Sci Mater Med 9: 749-754.
35. Lange C, Cakiroglu F, Spiess AN, et al. 2007; Accelerated and safe expansion of human mesenchymal stromal cells in animal serumfree medium for transplantation and regenerative medicine. J Cell Physiol 213: 18-26.
36. Lee CR, Grodzinsky AJ, Hsu HP, et al. 2000; Effects of harvest and selected cartilage repair procedures on the physical and biochemical properties of articular cartilage in the canine knee. J Orthop Res 18: 790-799.
37. Lennon DP, Haynesworth SE, Young RG, et al. 1995; A chemically defined medium supports in vitro proliferation and maintains the osteochondral potential of rat marrow-derived mesenchymal cells. Exp Cell Res 219: 211-222.
38. Lim SM, Choi YS, Shin HC, et al. 2005; Isolation of human periosteum-derived progenitor cells using immunophenotypes for chondrogenesis. Biotechnol Lett 27: 607-611.
39. Liu TM, Martina M, Hutmacher DW, et al. 2007; Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages. Stem Cells 25: 750-760.
40. Mackay AM, Beck SC, Murphy JM, et al. 1998; Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 4: 415-428.
41. Mandl EW, van der Veen SW, Verhaar JA, et al. 2002; Serumfree medium supplemented with high-concentration FGF2 for cell expansion culture of human ear chondrocytes promotes redifferentiation capacity. Tissue Eng 8: 573-580.
42. Mankin HJ. 1974; The reaction of articular cartilage to injury and osteoarthritis [second of two parts].N Engl J Med 291: 1335-1340.
43. Meuleman N, Tondreau T, Delforge A, et al. 2006; Human marrow mesenchymal stem cell culture: serum-free medium allows better expansion than classical α-MEM medium. Eur J Haematol 76: 309-316.
44. Mierisch CM, Cohen SB, Jordan LC, et al. 2002; Transforming growth factor-β in calcium alginate beads for the treatment of articular cartilage defects in the rabbit. Arthroscopy 18: 892-900.
45. Miura Y, Fitzsimmons JS, Commisso CN, et al. 1994; Enhancement of periosteal chondrogenesis in vitro. Dose-response for transforming growth factor-β1 (TGFβ1). Clin Orthop Relat Res 301: 271-280.
46. Müller I, Kordowich S, Holzwarth C, et al. 2006; Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy 8: 437-444.
47. Nakahara H, Bruder SP, Goldberg VM, et al. 1990; In vivo osteochondrogenic potential of cultured cells derived from the periosteum. Clin Orthop Relat Res 259: 223-232.
48. Nakahara H, Goldberg VM, Caplan AI. 1991; Culture-expanded human periosteal-derived cells exhibit osteochondral potential in vivo. J Orthop Res 9: 465-476.
49. O'Driscoll SW, Recklies AD, Poole AR. 1994; Chondrogenesis in periosteal explants. An organ culture model for in vitro study. J Bone Joint Surg (Am) 76A: 1042-1051.
50. O'Driscoll SW, Saris DB, Ito Y, et al. 2001; The chondrogenic potential of periosteum decreases with age. J Orthop Res 19: 95-103.
51. Ossendorf C, Kaps C, Kreuz PC, et al. 2007; Treatment of posttraumatic and focal osteoarthritic cartilage defects of the knee with autologous polymer-based three-dimensional chondrocyte grafts: 2-year clinical results. Arthritis Res Ther 9: R41.
52. Ossendorf C, Kreuz PC, Steinwachs MR, et al. 2007; Autologous chondrocyte implantation for the treatment of large full-thickness cartilage lesions of the knee. Saudi Med J 28: 1251-1256.
53. Piquette GN, Timms BG. 1990; Isolation and characterization of rabbit ovarian surface epithelium, granulosa cells, and peritoneal mesothelium in primary culture. In vitro Cell Dev Biol 26: 471-481.
54. Pittenger MF, Mackay AM, Beck SC, et al. 1999; Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-146.
55. Pulliainen O, Vasara AI, Hyttinen MM, et al. 2007; Poly-DL-lactic acid scaffold in the repair of porcine knee cartilage lesions. Tissue Eng 13: 1347-1355.
56. Reichenberger E, Beier F, Luvalle P, et al. 1992; Genomic organization and full-length cDNA sequence of human collagen-X. FEBS Lett 311: 305-310.
57. Solchaga LA, Penick K, Porter JD, et al. 2005; FGF-2 enhances the mitotic and chondrogenic potentials of human adult bonemarrowderived mesenchymal stem cells. J Cell Physiol 203: 398-409.
58. Stevens M, Qanadilo H, Langer R, et al. 2002; FGF-2 in combination with TGFβ1 enhances periosteum derived chondrogenesis in vitro. 4th International Cartilage Repair Society, Toronto, Canada.
59. Vukicevic S, Luyten FP, Reddi AH. 1989; Stimulation of the expression of osteogenic and chondrogenic phenotypes in vitro by osteogenin. Proc Natl Acad Sci USA 86: 8793-8797.
60. Walsh S, Jefferiss C, Stewart K, et al. 2000; Expression of the developmental markers STRO-1 and alkaline phosphatase in cultures of human marrow stromal cells: regulation by fibroblast growth factor (FGF)-2 and relationship to the expression of FGF receptors 1-4. Bone 27: 185-195.
61. Walsh S, Jefferiss CM, Stewart K, et al. 2003; IGF-I does not affect the proliferation or early osteogenic differentiation of human marrow stromal cells. Bone 33: 80-89.
62. Wang WG, Lou SQ, Ju XD, et al. 2003; In vitro chondrogenesis of human bone marrow-derived mesenchymal progenitor cells in monolayer culture: activation by transfection with TGFβ2. Tissue Cell 35: 69-77.
63. Winter A, Breit S, Parsch D, et al. 2003; Cartilage-like gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells. Arthrit Rheum 48: 418-429.
64. Zaragosi LE, Ailhaud G, Dani C. 2006; Autocrine fibroblast growth factor 2 signaling is critical for self-renewal of human multipotent adipose-derived stem cells. Stem Cells 24: 2412-2419.
65. Zuk PA, Zhu M, Mizuno H, et al. 2001; Multilineage cells from human adipose tissue: implications for cell- based therapies. Tissue Eng 7: 211-228.